BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35241222)

  • 1. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
    Forrest JK; Deeb GM; Yakubov SJ; Rovin JD; Mumtaz M; Gada H; O'Hair D; Bajwa T; Sorajja P; Heiser JC; Merhi W; Mangi A; Spriggs DJ; Kleiman NS; Chetcuti SJ; Teirstein PS; Zorn GL; Tadros P; Tchétché D; Resar JR; Walton A; Gleason TG; Ramlawi B; Iskander A; Caputo R; Oh JK; Huang J; Reardon MJ
    J Am Coll Cardiol; 2022 Mar; 79(9):882-896. PubMed ID: 35241222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Forrest JK; Deeb GM; Yakubov SJ; Gada H; Mumtaz MA; Ramlawi B; Bajwa T; Teirstein PS; DeFrain M; Muppala M; Rutkin BJ; Chawla A; Jenson B; Chetcuti SJ; Stoler RC; Poulin MF; Khabbaz K; Levack M; Goel K; Tchétché D; Lam KY; Tonino PAL; Ito S; Oh JK; Huang J; Popma JJ; Kleiman N; Reardon MJ;
    J Am Coll Cardiol; 2023 May; 81(17):1663-1674. PubMed ID: 36882136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    Popma JJ; Deeb GM; Yakubov SJ; Mumtaz M; Gada H; O'Hair D; Bajwa T; Heiser JC; Merhi W; Kleiman NS; Askew J; Sorajja P; Rovin J; Chetcuti SJ; Adams DH; Teirstein PS; Zorn GL; Forrest JK; Tchétché D; Resar J; Walton A; Piazza N; Ramlawi B; Robinson N; Petrossian G; Gleason TG; Oh JK; Boulware MJ; Qiao H; Mugglin AS; Reardon MJ;
    N Engl J Med; 2019 May; 380(18):1706-1715. PubMed ID: 30883053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve.
    Attizzani GF; Dallan LAP; Markowitz A; Yakubov SJ; Deeb GM; Reardon MJ; Forrest JK; Mangi AA; Huang J; Popma JJ
    JACC Cardiovasc Interv; 2020 Aug; 13(15):1816-1824. PubMed ID: 32763073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
    Van Mieghem NM; Deeb GM; Søndergaard L; Grube E; Windecker S; Gada H; Mumtaz M; Olsen PS; Heiser JC; Merhi W; Kleiman NS; Chetcuti SJ; Gleason TG; Lee JS; Cheng W; Makkar RR; Crestanello J; George B; George I; Kodali S; Yakubov SJ; Serruys PW; Lange R; Piazza N; Williams MR; Oh JK; Adams DH; Li S; Reardon MJ;
    JAMA Cardiol; 2022 Oct; 7(10):1000-1008. PubMed ID: 36001335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
    Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.
    Van Mieghem NM; Popma JJ; Deeb GM; Yakubov SJ; Serruys PW; Windecker S; Søndergaard L; Mumtaz M; Gada H; Chetcuti S; Kleiman NS; Kodali S; George I; Teefy P; Kiaii B; Oh JK; Kappetein AP; Chang Y; Mugglin AS; Reardon MJ;
    JACC Cardiovasc Interv; 2020 Feb; 13(3):323-331. PubMed ID: 32029248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap.
    Forrest JK; Mangi AA; Popma JJ; Khabbaz K; Reardon MJ; Kleiman NS; Yakubov SJ; Watson D; Kodali S; George I; Tadros P; Zorn GL; Brown J; Kipperman R; Saul S; Qiao H; Oh JK; Williams MR
    JACC Cardiovasc Interv; 2018 Jan; 11(2):160-168. PubMed ID: 29348010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial.
    Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Hildick-Smith D; Cunnington M; Wolf A; Barbanti M; Tchetchè D; Garot P; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Deutsch O; Kempfert J; Søndergaard L; Butter C; Trillo-Nouche R; Lotfi S; Möllmann H; Joner M; Abdel-Wahab M; Bogaerts K; Hengstenberg C; Capodanno D
    Circulation; 2020 Dec; 142(25):2431-2442. PubMed ID: 33054367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
    Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry.
    Forrest JK; Kaple RK; Tang GHL; Yakubov SJ; Nazif TM; Williams MR; Zhang A; Popma JJ; Reardon MJ
    JACC Cardiovasc Interv; 2020 Jan; 13(2):170-179. PubMed ID: 31973793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Van Mieghem NM; Windecker S; Manoharan G; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Tchétché D; Finkelstein A; Ito S; Eisenberg R; Grube E
    Catheter Cardiovasc Interv; 2022 Jan; 99(1):171-178. PubMed ID: 34331844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
    Blanke P; Leipsic JA; Popma JJ; Yakubov SJ; Deeb GM; Gada H; Mumtaz M; Ramlawi B; Kleiman NS; Sorajja P; Askew J; Meduri CU; Kauten J; Melnitchouk S; Inglessis I; Huang J; Boulware M; Reardon MJ;
    J Am Coll Cardiol; 2020 May; 75(19):2430-2442. PubMed ID: 32234463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials.
    Braghiroli J; Kapoor K; Thielhelm TP; Ferreira T; Cohen MG
    Cardiovasc Diagn Ther; 2020 Feb; 10(1):59-71. PubMed ID: 32175228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
    Reardon MJ; Van Mieghem NM; Popma JJ; Kleiman NS; Søndergaard L; Mumtaz M; Adams DH; Deeb GM; Maini B; Gada H; Chetcuti S; Gleason T; Heiser J; Lange R; Merhi W; Oh JK; Olsen PS; Piazza N; Williams M; Windecker S; Yakubov SJ; Grube E; Makkar R; Lee JS; Conte J; Vang E; Nguyen H; Chang Y; Mugglin AS; Serruys PW; Kappetein AP;
    N Engl J Med; 2017 Apr; 376(14):1321-1331. PubMed ID: 28304219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients.
    Deeb GM; Reardon MJ; Ramlawi B; Yakubov SJ; Chetcuti SJ; Kleiman NS; Mangi AA; Zahr F; Song HK; Gada H; Mumtaz M; Heiser J; Merhi W; Murrah CP; Noel T; Kirshner M; Byrne T; Ito S; Huang J; Forrest JK
    JACC Cardiovasc Interv; 2022 Mar; 15(5):511-522. PubMed ID: 35272776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
    JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.
    Attizzani GF; Dallan LAP; Forrest JK; Reardon MJ; Szeto WY; Liu F; Pelletier M
    Catheter Cardiovasc Interv; 2022 Feb; 99(3):869-876. PubMed ID: 34533891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
    Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.